| JTS2400109 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JTS2400107 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JTS2400106 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JTS2400110 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JTS2400104 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Us Inc;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JTS2400105 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| JTS2400108 | 注射用培重组人凝血因子VIII | | Lyophilized | Biological Products | Disposable Import Drug Application | 2024-09-25 | | Baxalta Manufacturing Sàrl;Takeda Canada Inc;Takeda (China) International Trading Co Ltd | | | view |
| CXSB2300105 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| CXSB2300106 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | Supplementary Application | 2023-10-11 | | Jiangsu Shengsi Biopharmaceutical Co Ltd | | | view |
| CXSL2000373 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-12-23 | 海门晟斯生物制药有限公司 | Jiangsu Shengsi Biopharmaceutical Co Ltd | In Review | 2020-12-22 | view |
| CXSL2000372 | 注射用培重组人凝血因子VIII-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2020-12-23 | 海门晟斯生物制药有限公司 | Jiangsu Shengsi Biopharmaceutical Co Ltd | In Review | 2020-12-22 | view |
| JYSB2000401 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-01 | view |
| JYSZ1200013 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2012-04-05 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2014-06-06 | view |
| JYSB1800178 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-08-17 | | Wyeth Farma SA;Pfizer Ltd | Filed | 2018-08-23 | view |
| JYSB1000027 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2010-02-09 | | Bayer Healthcare LLC | Certificate Issued | 2010-12-27 | view |
| JXSS2200002 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |
| JYSB1500175 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-07-06 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-12-25 | view |
| JXSL1600041 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2016-07-11 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
| JYSB2300182 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-10-26 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB1900244 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-09-05 | | Wyeth Farma SA;Pfizer Ltd | Filed | 2019-09-16 | view |
